DUALAMS Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $30K
Latest Deal Amount
  • Investors
  • 1

DUALAMS General Information

Description

Developer of a medical instrument designed to ease patient pre-and post-operative experiences. The company's medical instrument offers to inject nebulized lidocaine which eases the process and eliminates reflex gagging, coughing, aspiration, bucking, and laryngospasm, enabling clinicians to perform the examinations efficiently.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Primary Office
  • 7139 Azalea
  • Dallas, TX 75230
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

DUALAMS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 31-Aug-2015 $30K 0000 Completed Generating Revenue
To view DUALAMS’s complete valuation and funding history, request access »

DUALAMS Executive Team (1)

Name Title Board Seat Contact Info
John Houston Founder & Chief Executive Officer
To view DUALAMS’s complete executive team members history, request access »

DUALAMS Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DUALAMS Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Health Wildcatters Accelerator/Incubator Minority 000 0000 000000 0
To view DUALAMS’s complete investors history, request access »